PATENT CLAIM ANALYSIS

Application Number: 15994094
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "291000"]

Abstract:
Methods are provided for the targeted treatment of Epidermolysis Bullosa simplex.

Claim (Index 4):
The method of  claim 3 , wherein the mTOR inhibitor is rapamycin.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14025485', '14963137', '11985850', '13520472', '14009751']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7406110378262287
- 35 USC 102 Novelty (BERT): 0.4570446803928882
- Combined Prediction Score: 0.7122544020828947
- Mean Citation Score: 124.5137508
- Max Citation Score: 176.03606000000005
- Similarity Product: 156.97041554172282

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test